BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 3159819)

  • 1. Phenotype of recovering lymphoid cell populations after marrow transplantation.
    Ault KA; Antin JH; Ginsburg D; Orkin SH; Rappeport JM; Keohan ML; Martin P; Smith BR
    J Exp Med; 1985 Jun; 161(6):1483-502. PubMed ID: 3159819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous mixed lymphocyte reaction (AMLR) in man. XVI. The AMLR and monoclonal antibody-defined T cell subsets and HNK 1+ natural killer cells in normal human pregnancy.
    Gupta S; Fanous E
    J Reprod Immunol; 1986 Apr; 9(1):1-9. PubMed ID: 2946861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry.
    Atkinson K
    Bone Marrow Transplant; 1986 Dec; 1(2):121-32. PubMed ID: 2971408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
    Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
    J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative and functional analysis of a human lymphocyte subset with the T-helper (Leu 3/T 4+) phenotype and natural killer (NK)-cell characteristics in patients with malignancy.
    Velardi A; Clement LT; Grossi CE
    J Clin Immunol; 1985 Sep; 5(5):329-39. PubMed ID: 2932461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults.
    Abo T; Miller CA; Balch CM
    Eur J Immunol; 1984 Jul; 14(7):616-23. PubMed ID: 6430709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis.
    Bengtsson M; Tötterman TH; Smedmyr B; Festin R; Oberg G; Simonsson B
    Leukemia; 1989 Jan; 3(1):68-75. PubMed ID: 2535882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
    Tedder TF; Clement LT; Cooper MD
    J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and expression of the HLA-DC antigens defined by anti-Leu 10.
    Chen YX; Evans RL; Pollack MS; Lanier LL; Phillips JH; Rousso C; Warner NL; Brodsky FM
    Hum Immunol; 1984 Aug; 10(4):221-35. PubMed ID: 6332101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence.
    Stites DP; Casavant CH; McHugh TM; Moss AR; Beal SL; Ziegler JL; Saunders AM; Warner NL
    Clin Immunol Immunopathol; 1986 Feb; 38(2):161-77. PubMed ID: 3510102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
    Damle NK; Doyle LV; Bradley EC
    J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large subpopulation of lymphocytes with T helper phenotype (Leu-3/T4+) exhibits the property of binding to NK cell targets and granular lymphocyte morphology.
    Velardi A; Grossi CE; Cooper MD
    J Immunol; 1985 Jan; 134(1):58-64. PubMed ID: 3155472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipients.
    Gottschalk LR; Bray RA; Kaizer H; Gebel HM
    Bone Marrow Transplant; 1990 Apr; 5(4):259-64. PubMed ID: 1692496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of T lymphocyte and monocyte populations in HLA B8/DRw3 normal individuals and in patients with dermatitis herpetiformis.
    Hall RP; Leiserson WM; Chused TM; Lawley TJ
    J Invest Dermatol; 1984 Mar; 82(3):231-4. PubMed ID: 6230405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of NK-lineage markers on peripheral blood lymphocytes with T-helper (Leu3+/T4+) phenotype in B cell chronic lymphocytic leukemia.
    Velardi A; Prchal JT; Prasthofer EF; Grossi CE
    Blood; 1985 Jan; 65(1):149-55. PubMed ID: 3155487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation.
    Hercend T; Takvorian T; Nowill A; Tantravahi R; Moingeon P; Anderson KC; Murray C; Bohuon C; Ythier A; Ritz J
    Blood; 1986 Mar; 67(3):722-8. PubMed ID: 3081066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation.
    Leroy E; Calvo CF; Divine M; Gourdin MF; Baujean F; Ben Aribia MH; Mishal Z; Vernant JP; Farcet JP; Senik A
    J Immunol; 1986 Oct; 137(7):2180-9. PubMed ID: 2944951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL; Benike CJ; Phillips JH; Engleman EG
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypical and functional studies on a subtype of suppressor cells (CD8+/CD11+) in patients after bone marrow transplantation.
    Klingemann HG; Lum LG; Storb R
    Transplantation; 1987 Sep; 44(3):381-6. PubMed ID: 2957835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.